From refering previous announcements and US investors presentation, my understanding PRR Phase 11b trials started in early 2010 in USA and Australia with 6 patients and then 60.
Further phase3 trial is to be conducted in europe in late 2010 running concurrently with phase 11b. If I am correct then the trials are been delay for what ever reason. If I am wrong I apologised.
I think we need clarafication from PRR on the trials if correct.
From refering previous announcements and US investors...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |